{"id":2427,"date":"2024-11-26T14:00:07","date_gmt":"2024-11-26T13:00:07","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/"},"modified":"2024-11-26T14:00:08","modified_gmt":"2024-11-26T13:00:08","slug":"la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/","title":{"rendered":"La FDA approuve Bimzelx pour l&rsquo;hidrosad\u00e9nite suppur\u00e9e"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2024\/fda-approves-bimzelx-f-1.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/2024\/fda-approves-bimzelx-f-1.jpg\" data-sub-html=\"\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 Bimzelx (bimekizumab-bkzx) d&rsquo;UCB pour le traitement des adultes atteints d&rsquo;hidrad\u00e9nite suppur\u00e9e mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re.<\/p>\n<p>Bimzelx devient le premier et le seul m\u00e9dicament approuv\u00e9 con\u00e7u pour inhiber s\u00e9lectivement l&rsquo;interleukine 17F en plus de l&rsquo;interleukine 17A et constitue la cinqui\u00e8me indication de Bimzelx aux \u00c9tats-Unis.<\/p>\n<p>L&rsquo;approbation est \u00e9tay\u00e9e par les donn\u00e9es de deux \u00e9tudes de phase III portant sur des adultes atteints d&rsquo;hidrosad\u00e9nite suppur\u00e9e mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re (BE HEARD I et BE HEARD II).<\/p>\n<p>Par rapport au placebo, les r\u00e9sultats ont montr\u00e9 qu&rsquo;une proportion plus \u00e9lev\u00e9e de patients trait\u00e9s par Bimzelx ont obtenu une am\u00e9lioration \u2265 50 pour cent des signes et sympt\u00f4mes de l&rsquo;hidrad\u00e9nite suppur\u00e9e \u00e0 la semaine 16, qui \u00e9tait le crit\u00e8re d&rsquo;\u00e9valuation principal mesur\u00e9 par la r\u00e9ponse clinique de l&rsquo;hidrad\u00e9nite suppur\u00e9e (HiSCR50).<\/p>\n<p>Le traitement par Bimzelx a \u00e9galement entra\u00een\u00e9 des am\u00e9liorations cliniquement significatives du crit\u00e8re d&rsquo;\u00e9valuation secondaire, HiSCR75, \u00e0 la semaine 16, par rapport au placebo. Les r\u00e9ponses cliniques ont \u00e9t\u00e9 soutenues jusqu&rsquo;\u00e0 la semaine 48, sans aucun nouveau signal de s\u00e9curit\u00e9 signal\u00e9.<\/p>\n<p>\u00ab\u00a0L&rsquo;approbation de Bimzelx dans le traitement de l&rsquo;hidrad\u00e9nite suppur\u00e9e mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re est la bienvenue \u00e9tant donn\u00e9 les besoins cliniques substantiels non satisfaits et le nombre limit\u00e9 d&rsquo;options de traitement disponibles aujourd&rsquo;hui\u00a0\u00bb, a d\u00e9clar\u00e9 Alexa B. Kimball, MD, chercheuse de BE HEARD, du centre m\u00e9dical Beth Israel Deaconess \u00e0 Boston. , a d\u00e9clar\u00e9 dans un communiqu\u00e9.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 Bimzelx (bimekizumab-bkzx) d&rsquo;UCB pour le traitement<\/p>\n","protected":false},"author":1,"featured_media":2428,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[321,2730,447,1465,8,1466],"class_list":["post-2427","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-approuve","tag-bimzelx","tag-fda","tag-lhidrosadenite","tag-pour","tag-suppuree","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La FDA approuve Bimzelx pour l&#039;hidrosad\u00e9nite suppur\u00e9e - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FDA approuve Bimzelx pour l&#039;hidrosad\u00e9nite suppur\u00e9e - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 Bimzelx (bimekizumab-bkzx) d&rsquo;UCB pour le traitement\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-26T13:00:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-26T13:00:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732626007_La-FDA-approuve-Bimzelx-pour-lhidrosadenite-suppuree.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"La FDA approuve Bimzelx pour l&rsquo;hidrosad\u00e9nite suppur\u00e9e\",\"datePublished\":\"2024-11-26T13:00:07+00:00\",\"dateModified\":\"2024-11-26T13:00:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/\"},\"wordCount\":285,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732626007_La-FDA-approuve-Bimzelx-pour-lhidrosadenite-suppuree.jpg\",\"keywords\":[\"approuve\",\"Bimzelx\",\"FDA\",\"lhidrosad\u00e9nite\",\"pour\",\"suppur\u00e9e\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/\",\"name\":\"La FDA approuve Bimzelx pour l'hidrosad\u00e9nite suppur\u00e9e - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732626007_La-FDA-approuve-Bimzelx-pour-lhidrosadenite-suppuree.jpg\",\"datePublished\":\"2024-11-26T13:00:07+00:00\",\"dateModified\":\"2024-11-26T13:00:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732626007_La-FDA-approuve-Bimzelx-pour-lhidrosadenite-suppuree.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732626007_La-FDA-approuve-Bimzelx-pour-lhidrosadenite-suppuree.jpg\",\"width\":1280,\"height\":853,\"caption\":\"La FDA approuve Bimzelx pour l'hidrosad\u00e9nite suppur\u00e9e\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La FDA approuve Bimzelx pour l&rsquo;hidrosad\u00e9nite suppur\u00e9e\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA approuve Bimzelx pour l'hidrosad\u00e9nite suppur\u00e9e - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/","og_locale":"fr_FR","og_type":"article","og_title":"La FDA approuve Bimzelx pour l'hidrosad\u00e9nite suppur\u00e9e - RVH-Synergie.org","og_description":"La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 Bimzelx (bimekizumab-bkzx) d&rsquo;UCB pour le traitement","og_url":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/","og_site_name":"RVH-Synergie","article_published_time":"2024-11-26T13:00:07+00:00","article_modified_time":"2024-11-26T13:00:08+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732626007_La-FDA-approuve-Bimzelx-pour-lhidrosadenite-suppuree.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"La FDA approuve Bimzelx pour l&rsquo;hidrosad\u00e9nite suppur\u00e9e","datePublished":"2024-11-26T13:00:07+00:00","dateModified":"2024-11-26T13:00:08+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/"},"wordCount":285,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732626007_La-FDA-approuve-Bimzelx-pour-lhidrosadenite-suppuree.jpg","keywords":["approuve","Bimzelx","FDA","lhidrosad\u00e9nite","pour","suppur\u00e9e"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/","url":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/","name":"La FDA approuve Bimzelx pour l'hidrosad\u00e9nite suppur\u00e9e - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732626007_La-FDA-approuve-Bimzelx-pour-lhidrosadenite-suppuree.jpg","datePublished":"2024-11-26T13:00:07+00:00","dateModified":"2024-11-26T13:00:08+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732626007_La-FDA-approuve-Bimzelx-pour-lhidrosadenite-suppuree.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732626007_La-FDA-approuve-Bimzelx-pour-lhidrosadenite-suppuree.jpg","width":1280,"height":853,"caption":"La FDA approuve Bimzelx pour l'hidrosad\u00e9nite suppur\u00e9e"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-bimzelx-pour-lhidrosadenite-suppuree\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"La FDA approuve Bimzelx pour l&rsquo;hidrosad\u00e9nite suppur\u00e9e"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/2427","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=2427"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/2427\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/2428"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=2427"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=2427"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=2427"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}